Terms: = Uterine cancer AND BRIP1, MGC126521, 83990, ENSG00000136492, FANCJ, FLJ90232, Q9BX63, MGC126523, OF AND Prognosis
67 results:
1. Human Papillomavirus Detectability and Cervical cancer prognosis: A Systematic Review and Meta-analysis.
Volesky-Avellaneda KD; Laurie C; Tsyruk-Romano O; El-Zein M; Franco EL
Obstet Gynecol; 2023 Nov; 142(5):1055-1067. PubMed ID: 37856917
[TBL] [Abstract] [Full Text] [Related]
2. Multimolecular characteristics and role of BRCA1 interacting protein C-terminal helicase 1 (brip1) in human tumors: a pan-cancer analysis.
Wang R; Zhang J; Cui X; Wang S; Chen T; Niu Y; Du X; Kong J; Wang L; Jiang Y
World J Surg Oncol; 2023 Mar; 21(1):91. PubMed ID: 36907870
[TBL] [Abstract] [Full Text] [Related]
3. Adjuvant Therapy in Node-Positive Endometrial cancer: A Focus on Chemotherapy.
Dexter J; Lips E; DiSilvestro P
Curr Oncol Rep; 2022 Dec; 24(12):1677-1683. PubMed ID: 36417134
[TBL] [Abstract] [Full Text] [Related]
4. Clinical outcomes and survival following treatment of bone metastases from uterine leiomyosarcoma: A report of 6 cases.
Öztürk Başarır Z; Karaca MO; Balaban K; Başarır K
Acta Orthop Traumatol Turc; 2022 Jul; 56(4):278-282. PubMed ID: 35968620
[TBL] [Abstract] [Full Text] [Related]
5. Further refining 2020 ESGO/ESTRO/ESP molecular risk classes in patients with early-stage endometrial cancer: A propensity score-matched analysis.
Nero C; Pasciuto T; Cappuccio S; Corrado G; Pelligra S; Zannoni GF; Santoro A; Piermattei A; Minucci A; Lorusso D; Fanfani F; Scambia G
Cancer; 2022 Aug; 128(15):2898-2907. PubMed ID: 35617463
[TBL] [Abstract] [Full Text] [Related]
6. Genomic mutation features identify distinct BRCA-associated mutation characteristics in endometrioid carcinoma and endometrioid ovarian carcinoma.
Cao C; Yu R; Gong W; Liu D; Zhang X; Fang Y; Xia Y; Zhang W; Gao Q
Aging (Albany NY); 2021 Nov; 13(22):24686-24709. PubMed ID: 34837690
[TBL] [Abstract] [Full Text] [Related]
7. Advances in management of nonendometrioid endometrial carcinoma, with an emphasis on the sentinel lymph node technique.
Eriksson AGZ; Mueller JJ
Curr Opin Oncol; 2021 Sep; 33(5):457-463. PubMed ID: 34264897
[TBL] [Abstract] [Full Text] [Related]
8. Impact of Molecular Classification on Treatment Paradigms in uterine cancers.
Cosgrove CM; Barrington D; Backes FJ
Curr Oncol Rep; 2021 May; 23(7):75. PubMed ID: 33937919
[TBL] [Abstract] [Full Text] [Related]
9. An immunohistochemical analysis of CD3, PD-L1, and CTLA-4 expression in carcinosarcomas of the gynecological tract and their metastases.
Karpathiou G; Chauleur C; Dal Col P; Dridi M; Hathroubi S; Mobarki M; Peoc'h M
Pathol Res Pract; 2020 Aug; 216(8):153028. PubMed ID: 32703493
[TBL] [Abstract] [Full Text] [Related]
10. Morcellation of the Uterus: Is There Any Place?
Halaska MJ; Gracia M; Laky R; Zapardiel I
Curr Oncol Rep; 2020 Jun; 22(7):68. PubMed ID: 32514869
[TBL] [Abstract] [Full Text] [Related]
11. Ancestry-specific predisposing germline variants in cancer.
Oak N; Cherniack AD; Mashl RJ; ; Hirsch FR; Ding L; Beroukhim R; Gümüş ZH; Plon SE; Huang KL
Genome Med; 2020 May; 12(1):51. PubMed ID: 32471518
[TBL] [Abstract] [Full Text] [Related]
12. A-kinase-interacting protein 1 promotes EMT and metastasis via PI3K/Akt/IKKβ pathway in cervical cancer.
Zhang X; Liu S; Zhu Y
Cell Biochem Funct; 2020 Aug; 38(6):782-791. PubMed ID: 32401379
[TBL] [Abstract] [Full Text] [Related]
13. ABO blood type compatibility is not a risk factor for gestational trophoblastic neoplasia development from androgenetic complete hydatidiform moles.
Sato A; Usui H; Shozu M
Am J Reprod Immunol; 2020 Jun; 83(6):e13237. PubMed ID: 32191360
[TBL] [Abstract] [Full Text] [Related]
14. Multiparametric MRI-Based Radiomics Nomogram for Predicting Lymph Node Metastasis in Early-Stage Cervical cancer.
Xiao M; Ma F; Li Y; Li Y; Li M; Zhang G; Qiang J
J Magn Reson Imaging; 2020 Sep; 52(3):885-896. PubMed ID: 32096586
[TBL] [Abstract] [Full Text] [Related]
15. Circulating Transcripts and Biomarkers in uterine Tumors: Is There a Predictive Role?
De Bruyn C; Baert T; Van den Bosch T; Coosemans A
Curr Oncol Rep; 2020 Jan; 22(2):12. PubMed ID: 31997106
[TBL] [Abstract] [Full Text] [Related]
16. The immune checkpoints CTLA-4 and PD-L1 in carcinomas of the uterine cervix.
Karpathiou G; Chauleur C; Mobarki M; Peoc'h M
Pathol Res Pract; 2020 Jan; 216(1):152782. PubMed ID: 31862202
[TBL] [Abstract] [Full Text] [Related]
17. Molecular characterization of endometrial cancer and therapeutic implications.
Winterhoff B; Thomaier L; Mullany S; Powell MA
Curr Opin Obstet Gynecol; 2020 Feb; 32(1):76-83. PubMed ID: 31851045
[TBL] [Abstract] [Full Text] [Related]
18. Junctional zone endometrium alterations in gynecological and obstetrical disorders and impact on diagnosis, prognosis and treatment.
Tanos V; Balami S; Lingwood L
Curr Opin Obstet Gynecol; 2019 Dec; 31(6):418-427. PubMed ID: 31573995
[TBL] [Abstract] [Full Text] [Related]
19. Selecting Adjuvant Treatment for Endometrial Carcinoma Using Molecular Risk Factors.
Wortman BG; Nout RA; Bosse T; Creutzberg CL
Curr Oncol Rep; 2019 Jul; 21(9):83. PubMed ID: 31367798
[TBL] [Abstract] [Full Text] [Related]
20. Reclassifying endometrial carcinomas with a combined morphological and molecular approach.
Carlson J; McCluggage WG
Curr Opin Oncol; 2019 Sep; 31(5):411-419. PubMed ID: 31261170
[TBL] [Abstract] [Full Text] [Related]
[Next]
